Develops molecular glue degraders to create innovative medicines targeting previously undruggable proteins in human health.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Neomorph is building a leading protein degradation entity, focused on ‘molecular glue’ degraders. Neomorph’s mission is to use this technology to solve critical problems in human health with the discovery and development of innovative new medicines against ‘undruggable targets.’
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Neomorph Management Team
Investors
Deerfield Management Company
Neomorph Valuations & Financials
View real-time NPM data on Neomorph stock including daily Neomorph stock price estimates, valuation history, and historical share price information. Access Neomorph financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Neomorph pricing across six independent market signals. Looking for private company due diligence data sources on Neomorph? Get in touch to learn more.
Similar Companies
like Neomorph
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Nucs Ai
Healthcare & Life Sciences
Provides clinicians imaging data with outcome predictions for PSMA-targeted therapies and tumor burden quantification.
Solv Health
Healthcare & Life Sciences
Architects cloud-based healthcare networks to streamline same-day clinical booking and medical insurance verification.
Vyrl
Media & Entertainment
Connects brands and creators through a curated influencer network that enables collaborations, content, and commerce in one seamless hub.
Enboarder
Enterprise Software
A global leader in employee onboarding that helps enterprises deliver best practice HR processes to build and sustain high performance at scale.
Zephyr AI
AI & Machine Learning
Empowering smarter drug and diagnostic development by turning real-world clinicogenomic data into predictive insights via AI.
ProVen
FinTech
Offers tax-efficient investment solutions for UK SMEs through VCTs and EPS, providing tax relief and steady returns.
Remark
AI & Machine Learning
AI retail platform that enables guided shopping experiences which combine expert knowledge with scalable digital assistance.
The Snow League
Media & Entertainment
Hosts global snowboarding and freeskiing competitions, producing live events and media for worldwide winter sports fans.
FAQ
We have answers
Neomorph stock does not trade on public stock exchanges. Neomorph stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Neomorph stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Neomorph Stock does not trade on public stock exchanges. In order to sell Neomorph shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Neomorph does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Neomorph share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Neomorph stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Neomorph stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Neomorph stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Neomorph is a private company and has not had an IPO. There is currently no Neomorph IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Neomorph IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
